Wells Fargo’s Gilead Sciences GILD Stock Holding History

Wells Fargo’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-100,000	Closed	-$5.95M	–	7039
2022 Q1	$5.95M	Buy	100,000 +25,500	+34%	+$1.63M	﹤0.01%	2300
2021 Q4	$5.41M	Buy	+74,500	New	+$5.13M	﹤0.01%	2492
2021 Q1	–	Sell	-161,100	Closed	-$111K	–	7044
2020 Q4	$111K	Sell	161,100 -138,900	-46%	-$8.38M	﹤0.01%	5319
2020 Q3	$30K	Buy	+300,000	New	+$20.8M	﹤0.01%	5655
2020 Q2	–	Sell	-101,200	Closed	-$507K	–	6480
2020 Q1	$507K	Sell	101,200 -98,800	-49%	-$6.83M	﹤0.01%	4024
2019 Q4	$57K	Buy	200,000 +155,000	+344%	+$10.1M	﹤0.01%	5472
2019 Q3	$8K	Sell	45,000 -51,600	-53%	-$3.37M	﹤0.01%	5979
2019 Q2	$365K	Buy	+96,600	New	+$6.35M	﹤0.01%	4599
2018 Q4	–	Sell	-80,000	Closed	-$19K	–	6479
2018 Q3	$19K	Hold	80,000	–	–	﹤0.01%	5838
2018 Q2	$31K	Sell	80,000 -15,000	-16%	-$1.06M	﹤0.01%	5725
2018 Q1	$269K	Buy	95,000 +60,000	+171%	+$4.77M	﹤0.01%	4812
2017 Q4	$82K	Hold	35,000	–	–	﹤0.01%	5379
2017 Q3	$247K	Sell	35,000 -15,000	-30%	-$1.15M	﹤0.01%	4813
2017 Q2	$182K	Sell	50,000 -19,700	-28%	-$1.31M	﹤0.01%	4842
2017 Q1	$17K	Sell	69,700 -104,000	-60%	-$7.31M	﹤0.01%	5746
2016 Q4	$153K	Buy	173,700 +50,000	+40%	+$3.72M	﹤0.01%	4912
2016 Q3	$469K	Buy	+123,700	New	+$10M	﹤0.01%	3983
2016 Q1	–	Sell	-500	Closed	-$9K	–	6280
2015 Q4	$9K	Buy	+500	New	+$52K	﹤0.01%	5758

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo's GILD Position: Q2 2026 in Review

Wells Fargo reduced its Gilead Sciences (GILD) stake by 2.8% in Q2 2026, selling an estimated $24.9M and leaving 6,439,586 shares worth $814M. The position accounts for 0.13% of the portfolio, ranked #145.

Wells Fargo first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.59B in Q2 2015. 2,287 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Wells Fargo held 6,439,586 shares of Gilead Sciences worth $814M as of Q2 2026.
Wells Fargo sold 188,855 Gilead Sciences shares in Q2 2026, an estimated $24.9M.
Gilead Sciences made up 0.13% of Wells Fargo's portfolio in Q2 2026, its #145 holding.
Wells Fargo first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
Wells Fargo's Gilead Sciences position peaked at $1.59B in Q2 2015.
2,287 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.